AI may speed up heart procedure for dangerous rhythm disorder

NCT ID NCT06138873

First seen Jun 26, 2026 ยท Last updated Jun 26, 2026

Summary

This study tests whether using an AI tool (Ablation Index) during heart ablation can shorten the procedure for patients with ventricular tachycardia caused by prior heart attacks. About 100 adults with ischemic cardiomyopathy and scar-related VT will be randomly assigned to standard ablation or AI-guided ablation. The main goal is to see if AI guidance reduces the time radiofrequency energy is applied.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Ablation-index guided radiofrequency catheter ablation
What this could lead to
If successful, this could make heart ablation procedures faster and more efficient for patients with scar-related ventricular tachycardia.
What could go wrong
This is a small, early-phase trial (100 participants) testing a procedural technique, not a new drug. The benefit may be modest or not translate to better long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC CARDIOMYOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mass General Brigham and Women's Hospital

    NOT_YET_RECRUITING

    Boston, Massachusetts, 02115, United States

  • Mayo Clinic

    NOT_YET_RECRUITING

    Rochester, Minnesota, 55905, United States

  • Medical University of Michigan

    NOT_YET_RECRUITING

    Ann Arbor, Michigan, 48109, United States

  • Medical University of South Carolina

    NOT_YET_RECRUITING

    Charleston, South Carolina, 29425, United States

  • Rush University Medical Center

    RECRUITING

    Chicago, Illinois, 60614, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.